Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • Our Views
  • Magazine
  • Headlines
  • Store

FDA Approval

Elon Musk's Neuralink Sets Sail on Human Trials for Brain Implants, Paving Way For Paralysis Recovery

Bhuvan Krishna
1y Technology
image

Eisai’s Lecanemab Drug  For Alzheimer’s Gets Breakthrough Therapy Designation From US FDA

Swarajya Staff
4y Insta
image

FDA's Approval Of Aduhelm, First New Drug For Alzheimer's Disease In Nearly 20 years, Offers Hope For Millions

Swarajya Staff
4y Analysis
image

FDA Finds Moderna Coronavirus Vaccine ‘Highly Effective’, Set To Grant Emergency Use Authorisation On Friday

Swarajya Staff
4y Insta
image

Precision Medicine: FDA Approve ‘Wonder Drug’ That Treats Cancers Based On DNA And Not The Tumour

Swarajya Staff
6y Insta
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo